Patient safety & quality control Compounded GLP-1 drugs have had quality variability and even unsafe/illegal versions in the market FDA is trying to ensure patients get standardized, approved formulations This aligns with FDAs core principle: approved drugs = known safety, dosing, manufacturing controls 2) Prevents copycat mass production Compounding is legally meant for special cases, not large-scale alternatives The GLP-1 boom led to industrial-scale compounding (especially via telehealth) FDA is essentially saying: this has gone beyond its intended use To me, it should be done in combination with large scale initiatives to significantly improve access and affordability
Description GLUTANEX SOAP WITH GLUTATHIONE Glutanex Soap is an extraordinary soap is enriched with a potent blend of skin-loving ingredients, including glutathione, hyaluronic acid, and natural fats derived from coconut and palm
Tang D, Chen X, Kroemer G
(f) Vildagliptin PDB ID 3w2t (Nabeno et al., 2013)
Reviews in Endocrine and Metabolic Disorders, 23(5), 979994